Prostate cancer (PCa) poses a significant global health threat, with high incidence and mortality rates. In 2022, the Council of the European Union (EU) updated its screening recommendations, prioritizing PCa screening. This signals a crucial step towards establishing new early detection programmes in EU member states. This study investigates the role of policy makers and governance in cancer screening to inform the development of PCa screening. We had a mixed-method study design. First, a rapid review was conducted on policy making and governance in EU-funded cancer screening initiatives. Second, a focus group discussion reviewed study concepts and methods. Third, a systematic literature review was performed and, fourth, a series of in-depth interviews with actors involved in PCa screening pilots was conducted. Data were analysed thematically and the findings are used to propose 10 recommendations for policy makers. The results of the rapid review and focus group discussion framed the study in the context of existing cancer screening programmes across the EU, and highlighted what already exists in terms of governance tools and methodology. The literature review and in-depth interviews presented key learnings from the literature and real-life settings. These findings are reported using a pre-existing conceptional framework for effective health system governance. The study underscores the critical importance of governance in effective cancer screening programmes. Ten recommendations are proposed, including: defining cancer screening governance, allocating budgets and defining common approaches and key performance indicators for evaluation, establishing methods to enhance citizen participation, and reinforcing network governance.

Background: The historical and cultural importance of traditional, complementary, and integrative medicine (TCIM) is observable in diverse contexts and among different populations. As the use of TCIM continues to grow globally, policymakers need to acknowledge its importance in healthcare services. Objectives: We conducted a scoping review of quantitative, qualitative, and mixed-method research to identify the factors that promote and hinder the adoption of TCIM. Methods: This scoping review involved a comprehensive search of online databases from 2000 to February 2024. The review utilized the methodology suggested by Arksey and O'Malley. Qualitative content analysis was employed to synthesize the data. Findings: From a total of 1403 articles retrieved, 61 full-text articles were chosen for the final analysis. Among these, 47 examined facilitators, 4 addressed barriers, and 10 investigated both barriers and facilitators of using TCIM. Three key themes were recognized concerning barriers to using TCIM services, including "service delivery problems", "governance challenges", and "personal barriers". Six key themes associated with the factors facilitating the use of TCIM services were recognized, which include "financial facilitators", "health conditions", "personal determinants", "perceived benefits", "social impact", and "appropriate service delivery". Conclusions: Exploring the barriers and facilitators of using TCIM services can provide valuable insights to policymakers, enabling them to develop strategies to overcome existing challenges and enhance the support for the growth of these services. This knowledge is essential for making sure that TCIM services are available to people in a safe, prompt, and high-quality way.

Background: To refine the methods of developing clinical practice guidelines (CPGs) for integrative ChineseWestern medicine (ICWM), promoting the formation of trustworthy, implementable recommendations that integrate the strengths of Chinese and Western medicine. Methods: Using a nominal group technique (NGT) approach, a multidisciplinary expert panel was established. The panel identified key methodological issues in ICWM-CPG development through literature review and iterative discussions, and formulated methodological proposals to address these issues. The final set of proposals was achieved through consensus among the panel members. Results: The collaborative effort resulted in the identification of five pivotal methodological issues and the subsequent establishment of 22 specific recommendations. These encompass strict adherence to renowned standards, such as those proposed by the Institute of Medicine (IOM) and Guidelines International Network (G -I -N), the employment of methodologies like the GRADE approach and RIGHT statement, the strategic constitution of a balanced development group, the adept identification of ICWM-focused clinical inquiries, the nuanced integration of diverse evidence sources, and the detailed crafting of transparent, implementable recommendations. Conclusions: This study concentrates on the most crucial and prevalent methodological issues in ICWM-CPG development, proposing a series of recommendations. These suggestions result from a multidisciplinary expert consensus, aiming to provide methodological guidance for ICWM-CPG developers, building upon the current foundational methodologies.